克罗恩病
本文是一篇面向医生的成人克罗恩病综述,涵盖流行病学、病因、临床诊断、自然史、患者分层与临床管理,并概述新兴疗法与未来研究方向。文章强调达标治疗策略,即对高危患者早期使用免疫抑制或生物制剂联合治疗并密切监测炎症以调整方案。
要点
- 克罗恩病为慢性胃肠道炎症性疾病,全球发病率上升,可能由遗传易感、环境因素与肠道菌群改变共同作用导致免疫失调。
- 典型临床场景为年轻患者出现腹痛、慢性腹泻、体重下降和乏力。
- 当前策略追求深度持久缓解以预防手术等并发症并阻断疾病进展,核心为高危患者早期免疫抑制或生物制剂联合治疗加达标治疗。
核心结论
- 克罗恩病治疗策略旨在实现深度持久缓解,预防手术等并发症并阻断疾病进展,核心为高危患者早期免疫抑制或生物制剂联合治疗联合密切频繁的炎症控制及据此调整治疗的达标治疗策略。
- 开发能预测治疗反应的生物标志物对不久将来的个体化医疗决策将日益重要。
研究设计与样本
- 本文为面向医生的成人克罗恩病综述(Seminar),涵盖流行病学、病因、临床诊断、自然史、患者分层与临床管理,并概述新兴疗法与未来研究方向。
主要发现
- 克罗恩病可能由遗传易感性、环境因素与改变的肠道菌群之间复杂相互作用引起,导致先天性和适应性免疫反应失调。
- 典型临床场景为年轻患者出现腹痛、慢性腹泻、体重下降和乏力。
- 评估疾病范围和并发症预后因素对指导治疗决策至关重要。
- 克罗恩病治疗手段正在扩展。
临床怎么用
- 当前策略追求深度持久缓解,以预防手术等并发症并阻断疾病进展。
- 对高危患者早期引入免疫抑制或生物制剂联合治疗,联合密切频繁的炎症控制,并基于该评估调整治疗(达标治疗策略)。
- 作者指出开发能预测治疗反应的生物标志物对个体化医疗决策将日益重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract, with increasing incidence worldwide. Crohn's disease might result from a complex interplay between genetic susceptibility, environmental factors, and altered gut microbiota, leading to dysregulated innate and adaptive immune responses. The typical clinical scenario is a young patient presenting with abdominal pain, chronic diarrhoea, weight loss, and fatigue. Assessment of disease extent and of prognostic factors for complications is paramount to guide therapeutic decisions. Current strategies aim for deep and long-lasting remission, with the goal of preventing complications, such as surgery, and blocking disease progression. Central to these strategies is the introduction of early immunosuppression or combination therapy with biologicals in high-risk patients, combined with a tight and frequent control of inflammation, and adjustment of therapy on the basis of that assessment (treat to target strategy). The therapeutic armamentarium for Crohn's disease is expanding, and therefore the need to develop biomarkers that can predict response to therapies will become increasingly important for personalised medicine decisions in the near future. In this Seminar, we provide a physician-oriented overview of Crohn's disease in adults, ranging from epidemiology and cause to clinical diagnosis, natural history, patient stratification and clinical management, and ending with an overview of emerging therapies and future directions for research.
引用
- Torres J, Mehandru S, Colombel JF, et al. Crohn's disease. Lancet. 2016. PMID: 27914655. doi:10.1016/S0140-6736(16)31711-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。